ERBB2 and breast carcinoma: In addition, to the role of ERBB2, the role of ER activation in response to progesterone in breast cancer cells is also critical, as shown in Figure 4C we observe the coordinated activation of the ESR1-Src-PIK3 complex peaking at 15 minutes following hormone exposure.